RZB tx resulted in statistically greater improvements in signs/ symptoms of PsA vs PBO and was well tolerated w/ no new safety signals. Plenary Abs 0453 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/c9RJdWlmpO https://t.co/MDbdAhdnIy
Links:
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 24-Week Int…
http://ow.ly/fgJQ50Gqjwk
06-11-2021
